{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:51:08Z","timestamp":1783947068050,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bcmd.2011.09.003","type":"journal-article","created":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T03:57:34Z","timestamp":1318651054000},"page":"255-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The presence of -308A TNF\u03b1 is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes"],"prefix":"10.1016","volume":"47","author":[{"given":"Carolina B.","family":"Belli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesica","family":"Bestach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamila","family":"Sieza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gelemur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda G.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Watman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Bengi\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Larripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2011.09.003_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0010","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0015","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes","volume":"361","author":"Tefferi","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","article-title":"A role for tumor necrosis factor-\u03b1, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome","volume":"103","author":"Gersuk","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0025","first-page":"1648","article-title":"A paradigm shift in myelodysplastic syndromes","volume":"10","author":"Raza","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0030","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1073\/pnas.0712391105","article-title":"Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function","volume":"105","author":"Marcondes","year":"2008","journal-title":"Proceedings of the National Academy of Science"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0035","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1080\/10428190802322919","article-title":"Inhibition of p38\u03b1 MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment","volume":"49","author":"Navas","year":"2008","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3835(99)00072-5","article-title":"Correlation of tumor necrosis factor a (TNFa) with high caspase 3-like activity in myelodysplastic syndromes","volume":"140","author":"Mundle","year":"1999","journal-title":"Cancer Letters"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10428190009089441","article-title":"Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome","volume":"37","author":"Deeg","year":"2000","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0050","first-page":"1268","article-title":"Measurement of serum cytokine levels in patients with myelodysplastic syndromes","volume":"6","author":"Verhoef","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2257.1997.tb00007.x","article-title":"Serum levels of tumour necrosis factor-alpha predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome","volume":"19","author":"Stasi","year":"1997","journal-title":"Clinical and Laboratory Haematology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0060","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cncr.23785","article-title":"The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-0609.2005.00551.x","article-title":"Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis","volume":"75","author":"Stifter","year":"2005","journal-title":"European Journal of Haematology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","article-title":"The \u2212308 tumor necrosis factor-alpha promoter polymorphism effects transcription","volume":"34","author":"Kroeger","year":"1997","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0075","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.5858\/2007-131-1789-PITATA","article-title":"Polymorphisms in TGF\u00df and TNF\u03b1 are associated with the myelodysplastic syndrome phenotype","volume":"131","author":"Powers","year":"2007","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0080","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2141.2002.03452.x","article-title":"Allele and haplotype frequency at human leucocyte antigen class I\/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology","volume":"117","author":"Gowans","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0085","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2141.2010.08254.x","article-title":"Single nucleotide polymorphisms in the human TNF gene are associated with anaemia and neutropenia in a cohort of patients with de novo myelodysplastic syndrome","volume":"150","author":"Parnes","year":"2010","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0090","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bbmt.2010.06.003","article-title":"Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous leukemia, independent of the presence of HLA-DR15","volume":"16","author":"Newell","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000084121","article-title":"Clinical importance of transforming growth factor-beta but not of tumor necrosis factor-alpha gene polymorphisms in patients with the myelodysplastic syndrome belonging to the refractory anemia subtype","volume":"72","author":"Balog","year":"2005","journal-title":"Pathobiology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000084681","article-title":"TNF-alpha promoter gene polymorphism in patients with myelodysplastic syndrome","volume":"113","author":"K\u00e1d\u00e1r","year":"2005","journal-title":"Acta Haematologica"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","article-title":"Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product","volume":"1","author":"Wilson","year":"1992","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0110","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","article-title":"Fas antigen expression on CD34+ human marrow cells is induced by interferon \u03b3 and tumor necrosis factor \u03b1 and potentiates cytokine-mediated hematopoietic suppression in vitro","volume":"85","author":"Maciejewski","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0115","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1182\/blood.V85.4.989.bloodjournal854989","article-title":"Tumor necrosis factor (TNF)-a directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors","volume":"85","author":"Rusten","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0120","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1158\/1078-0432.CCR-06-0254","article-title":"Effect of cA2 anti-tumor necrosis factor-A antibody therapy on hematopoiesis of patients with myelodysplastic syndromes","volume":"12","author":"Boula","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0145-2126(01)00201-6","article-title":"Pilot study of recombinant human soluble tumor necrosis factor receptor (TNFR:Fc) in patients with low risk myelodysplastic syndrome","volume":"26","author":"Rosenfeld","year":"2002","journal-title":"Leukemia Research"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2141.2002.03381.x","article-title":"A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome","volume":"117","author":"Maciejewski","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.leu.2402356","article-title":"Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study","volume":"16","author":"Deeg","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0140","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2141.2010.08145.x","article-title":"Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study","volume":"149","author":"Scott","year":"2010","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.bcmd.2011.09.003_bb0145","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1365-2141.2009.08061.x","article-title":"Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept","volume":"148","author":"Scott","year":"2010","journal-title":"British Journal of Haematology"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979611001719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979611001719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:28:14Z","timestamp":1761049694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979611001719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1079979611001719"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2011.09.003","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The presence of -308A TNF\u03b1 is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2011.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}